{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:29:53Z","timestamp":1788532193588,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Several factors contribute to the development of malignant lymphomas including environmental exposures, bacterial and viral infections, as well as familial and genetic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Numerous somatic variants are involved in lymphomagenesis, and an increasing number of germline variants predisposing patients to lymphoid neoplasm have been identified. Although most lymphomas arise sporadically, epidemiological studies have linked a familial history of lymphomas and other hematological tumors with an increased lymphoma risk. Although rare, familial clustering of malignant lymphoma is well documented, and the constellations suggest inherited risk factors. Recent technological advancements have improved our ability to identify genetic factors associated with lymphoma that overall lead to a better understanding of genetic susceptibility for these entities. In this context, we here provide a comprehensive perspective on lymphoma risk factors to support improved lymphoma risk assessment and testing. A dedicated clinical management could influence future advances in lymphoma therapies and might also prevent severe toxicity and secondary malignancies. However, to date, only few susceptibility genes for malignant lymphomas have been identified. Highly penetrant mutations in known genes cannot account for most of the excess in a polygenic and heterogenic disease such as cancer. High-throughput sequencing identifies pathogenic variants that may constitute most low-penetrance alleles. However, their detection requires many well-characterized cases and controls. In this review, we therefore also include a short discussion on a Swiss cohort where we prospectively collect and samples for genetic data from individuals with a family history of lymphoma. We are convinced that such an approach is more informative and feasible than a population-based project with unselected cases and aim to better inform both genetic counsellors and oncologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inherited genetic factors contribute to lymphoma risk in a subset of patients. Improved identification of susceptibility variants, particularly through family-based studies, may enhance risk assessment and inform personalized clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-026-02411-9","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:49:53Z","timestamp":1781783393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Familial lymphoma and genetic predisposition: an updated review"],"prefix":"10.1186","volume":"19","author":[{"given":"Laura","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Graffeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalaruban","family":"Kapilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet Kaur","family":"Mandhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Rabaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7642-2101","authenticated-orcid":false,"given":"Urban","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"11","key":"2411_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229\u201353.","journal-title":"Blood"},{"key":"2411_CR2","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBdO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348.","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"7","key":"2411_CR3","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292\u2013302.","journal-title":"Blood"},{"issue":"48","key":"2411_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","volume":"2014","author":"LM Morton","year":"2014","unstructured":"Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):130\u201344.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"19 Suppl","key":"2411_CR5","first-page":"5468s","volume":"52","author":"MS Linet","year":"1992","unstructured":"Linet MS, Pottern LM. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin\u2019s lymphoma. Cancer Res. 1992;52(19 Suppl):5468s-s5473.","journal-title":"Cancer Res"},{"issue":"2","key":"2411_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1182\/blood-2005-01-0140","volume":"106","author":"A Altieri","year":"2005","unstructured":"Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood. 2005;106(2):668\u201372.","journal-title":"Blood"},{"issue":"19","key":"2411_CR7","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/jnci\/dji293","volume":"97","author":"ET Chang","year":"2005","unstructured":"Chang ET, Smedby KE, Hjalgrim H, Porwit-MacDonald A, Roos G, Glimelius B, et al. Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst. 2005;97(19):1466\u201374.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2411_CR8","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1158\/1055-9965.EPI-05-0346","volume":"14","author":"LR Goldin","year":"2005","unstructured":"Goldin LR, Landgren O, McMaster ML, Gridley G, Hemminki K, Li X, et al. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer epidemiology, biomarkers & prevention\u202f: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14(10):2402\u20136.","journal-title":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"8","key":"2411_CR9","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2006-06-031948","volume":"109","author":"SS Wang","year":"2007","unstructured":"Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109(8):3479\u201388.","journal-title":"Blood"},{"issue":"7","key":"2411_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3324\/haematol.11011","volume":"92","author":"CF Skibola","year":"2007","unstructured":"Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica. 2007;92(7):960\u20139.","journal-title":"Haematologica"},{"issue":"20","key":"2411_CR11","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1182\/blood-2015-04-537498","volume":"126","author":"JR Cerhan","year":"2015","unstructured":"Cerhan JR, Slager SL. Familial predisposition and genetic risk factors for lymphoma. Blood. 2015;126(20):2265\u201373.","journal-title":"Blood"},{"key":"2411_CR12","doi-asserted-by":"publisher","first-page":"1639819","DOI":"10.3389\/fonc.2025.1639819","volume":"15","author":"S Akhtar","year":"2025","unstructured":"Akhtar S, Mushtaq AH, Syed H, Elhassan TAM, Alzahrani MJ, Rauf MS, et al. Risk of hematological malignancies and anticipation in the families of patients with non-Hodgkin and Hodgkin lymphoma. Front Oncol. 2025;15:1639819.","journal-title":"Front Oncol"},{"issue":"1","key":"2411_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2141.2009.07721.x","volume":"146","author":"LR Goldin","year":"2009","unstructured":"Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009;146(1):91\u20134.","journal-title":"Br J Haematol"},{"issue":"3","key":"2411_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/sj.bjc.6604881","volume":"100","author":"Y Lu","year":"2009","unstructured":"Lu Y, Sullivan-Halley J, Cozen W, Chang ET, Henderson K, Ma H, et al. Family history of haematopoietic malignancies and non-Hodgkin\u2019s lymphoma risk in the California Teachers Study. Br J Cancer. 2009;100(3):524\u20136.","journal-title":"Br J Cancer"},{"issue":"5","key":"2411_CR15","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/bjh.70397","volume":"208","author":"GA Cholack","year":"2026","unstructured":"Cholack GA, Mwangi R, Vodicka P, Habermann TM, Hinder V, Robinson DP, et al. Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes. Br J Haematol. 2026;208(5):1631\u201340.","journal-title":"Br J Haematol"},{"issue":"9","key":"2411_CR16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/cncr.20189","volume":"100","author":"LR Goldin","year":"2004","unstructured":"Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer. 2004;100(9):1902\u20138.","journal-title":"Cancer"},{"issue":"5","key":"2411_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.hoc.2010.06.001","volume":"24","author":"JE Churpek","year":"2010","unstructured":"Churpek JE, Onel K. Heritability of hematologic malignancies: from pedigrees to genomics. Hematol Oncol Clin North Am. 2010;24(5):939\u201372.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"2411_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125(4):591\u20139.","journal-title":"Blood"},{"issue":"6","key":"2411_CR19","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10897-016-9979-0","volume":"25","author":"M Similuk","year":"2016","unstructured":"Similuk M, Rao VK, Churpek J, Lenardo M. Predispositions to Lymphoma: A Practical Review for Genetic Counselors. J Genet Couns. 2016;25(6):1157\u201370.","journal-title":"J Genet Couns"},{"issue":"1","key":"2411_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000184","volume":"1","author":"X Shi","year":"2022","unstructured":"Shi X, Zhuo H, Du Y, Nyhan K, Ioannidis J, Wallach JD. Environmental risk factors for non-Hodgkin\u2019s lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data. BMJ Med. 2022;1(1):e000184.","journal-title":"BMJ Med"},{"key":"2411_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.123097","volume":"343","author":"T Taj","year":"2024","unstructured":"Taj T, Chen J, Rodopoulou S, Strak M, de Hoogh K, Poulsen AH, et al. Long-term exposure to ambient air pollution and risk of leukemia and lymphoma in a pooled European cohort. Environ Pollut. 2024;343:123097.","journal-title":"Environ Pollut"},{"key":"2411_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108386","volume":"788","author":"B Szmyd","year":"2021","unstructured":"Szmyd B, Mlynarski W, Pastorczak A. Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants. Mutat Res Rev Mutat Res. 2021;788:108386.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"2","key":"2411_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.15","volume":"7","author":"OC Leeksma","year":"2017","unstructured":"Leeksma OC, de Miranda NF, Veelken H. Germline mutations predisposing to diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(2):e532.","journal-title":"Blood Cancer J"},{"issue":"11","key":"2411_CR24","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1111\/cas.15522","volume":"113","author":"Y Usui","year":"2022","unstructured":"Usui Y, Iwasaki Y, Matsuo K, Endo M, Kamatani Y, Hirata M, et al. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer Sci. 2022;113(11):3972\u20139.","journal-title":"Cancer Sci"},{"issue":"1","key":"2411_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ijc.34892","volume":"155","author":"X Wang","year":"2024","unstructured":"Wang X, Deng L, Ping L, Shi Y, Wang H, Feng F, et al. Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families. Int J Cancer. 2024;155(1):93\u2013103.","journal-title":"Int J Cancer"},{"issue":"10","key":"2411_CR26","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.ajpath.2025.07.004","volume":"195","author":"A Molina-Alvarez","year":"2025","unstructured":"Molina-Alvarez A, Sanchez-Gonzalez B, Colomo L, Yelamos J. Poly (ADP-Ribose) Polymerase 1 and 2 in B-Cell Lymphoma: Pathogenic Roles and Therapeutic Implications. Am J Pathol. 2025;195(10):1776\u201387.","journal-title":"Am J Pathol"},{"key":"2411_CR27","doi-asserted-by":"publisher","first-page":"1322187","DOI":"10.3389\/fimmu.2024.1322187","volume":"15","author":"MJ Dennis","year":"2024","unstructured":"Dennis MJ, Bylsma S, Madlensky L, Pagadala MS, Carter H, Patel SP. Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy. Front Immunol. 2024;15:1322187.","journal-title":"Front Immunol"},{"issue":"9","key":"2411_CR28","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/jamaoncol.2019.2203","volume":"5","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wilson CL, Armstrong GT, Hudson MM, Zhang J, Nichols KE, et al. Association of Germline BRCA2 Mutations With the Risk of Pediatric or Adolescent Non-Hodgkin Lymphoma. JAMA Oncol. 2019;5(9):1362\u20134.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2411_CR29","first-page":"351","volume":"109","author":"RJ Stubbins","year":"2024","unstructured":"Stubbins RJ, Asom AS, Wang P, Lager AM, Gary A, Godley LA. Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies. Haematologica. 2024;109(1):351\u20136.","journal-title":"Haematologica"},{"issue":"1","key":"2411_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10689-020-00192-3","volume":"20","author":"AJ Scott","year":"2021","unstructured":"Scott AJ, Tokaz MC, Jacobs MF, Chinnaiyan AM, Phillips TJ, Wilcox RA. Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series. Fam Cancer. 2021;20(1):61\u20135.","journal-title":"Fam Cancer"},{"issue":"10","key":"2411_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140819","volume":"10","author":"O Havranek","year":"2015","unstructured":"Havranek O, Kleiblova P, Hojny J, Lhota F, Soucek P, Trneny M, et al. Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma. PLoS ONE. 2015;10(10):e0140819.","journal-title":"PLoS ONE"},{"issue":"3","key":"2411_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005945","volume":"12","author":"PJ Byrd","year":"2016","unstructured":"Byrd PJ, Stewart GS, Smith A, Eaton C, Taylor AJ, Guy C, et al. A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development. PLoS Genet. 2016;12(3):e1005945.","journal-title":"PLoS Genet"},{"key":"2411_CR33","doi-asserted-by":"crossref","unstructured":"Hernandez-Verdin I, Labreche K, Benazra M, Mokhtari K, Hoang-Xuan K, Alentorn A. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies. Int J Mol Sci. 2020;22(1):122.","DOI":"10.3390\/ijms22010122"},{"issue":"1","key":"2411_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41408-025-01351-4","volume":"15","author":"M Guler","year":"2025","unstructured":"Guler M, Canzian F. Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study. Blood Cancer J. 2025;15(1):147.","journal-title":"Blood Cancer J"},{"issue":"6","key":"2411_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287602","volume":"18","author":"S Ralli","year":"2023","unstructured":"Ralli S, Jones SJ, Leach S, Lynch HT, Brooks-Wilson AR. Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes. PLoS ONE. 2023;18(6):e0287602.","journal-title":"PLoS ONE"},{"issue":"1","key":"2411_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s12672-025-03101-1","volume":"16","author":"P Shi","year":"2025","unstructured":"Shi P, Baranova A, Cao H. Integrative genomic analysis identifies novel causal genes of Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma. Discov Oncol. 2025;16(1):1324.","journal-title":"Discov Oncol"},{"issue":"3","key":"2411_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nri3814","volume":"15","author":"K Basso","year":"2015","unstructured":"Basso K, Dalla-Favera R. Germinal centres and B cell lymphomagenesis. Nat Rev Immunol. 2015;15(3):172\u201384.","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"2411_CR38","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123(13):1989\u201399.","journal-title":"Blood"},{"issue":"12","key":"2411_CR39","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1084\/jem.20120831","volume":"209","author":"AL Snow","year":"2012","unstructured":"Snow AL, Xiao W, Stinson JR, Lu W, Chaigne-Delalande B, Zheng L, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med. 2012;209(12):2247\u201361.","journal-title":"J Exp Med"},{"key":"2411_CR40","doi-asserted-by":"crossref","unstructured":"OK Alkhairy R Perez-Becker GJ Driessen H Abolhassani J van Montfrans S Borte et al C Becker. Novel mutations in TNFRSF7\/CD27: clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol. 2015; 136(3)703-12. e10","DOI":"10.1016\/j.jaci.2015.02.022"},{"key":"2411_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-233482","author":"R Kishore","year":"2020","unstructured":"Kishore R, Gupta A, Gupta AK, Kabra SK. Novel mutation in the CD27 gene in a patient presenting with hypogammaglobulinemia, bronchiectasis and EBV-driven lymphoproliferative disease. BMJ Case Rep. 2020. https:\/\/doi.org\/10.1136\/bcr-2019-233482.","journal-title":"BMJ Case Rep"},{"issue":"12","key":"2411_CR42","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","volume":"95","author":"J Rohr","year":"2010","unstructured":"Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080\u20137.","journal-title":"Haematologica"},{"key":"2411_CR43","unstructured":"Zhang K, Astigarraga I, Bryceson Y, Lehmberg K, Machowicz R, Marsh R, et al. Familial Hemophagocytic Lymphohistiocytosis. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle. Copyright \u00a9 1993\u20132025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"5","key":"2411_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/his.12677","volume":"67","author":"K Bienemann","year":"2015","unstructured":"Bienemann K, Borkhardt A, Klapper W, Oschlies I. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency. Histopathology. 2015;67(5):607\u201316.","journal-title":"Histopathology"},{"issue":"5","key":"2411_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1399-3038.2012.01282.x","volume":"23","author":"H Kanegane","year":"2012","unstructured":"Kanegane H, Yang X, Zhao M, Yamato K, Inoue M, Hamamoto K, et al. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis. Pediatr Allergy Immunol. 2012;23(5):488\u201393.","journal-title":"Pediatr Allergy Immunol"},{"key":"2411_CR46","unstructured":"Meyer L, Hines M, Zhang K, Nichols KE. X-Linked Lymphoproliferative Disease. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle Copyright \u00a9 1993\u20132025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"4","key":"2411_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MOH.0b013e328353fa13","volume":"19","author":"E Leechawengwongs","year":"2012","unstructured":"Leechawengwongs E, Shearer WT. Lymphoma complicating primary immunodeficiency syndromes. Curr Opin Hematol. 2012;19(4):305\u201312.","journal-title":"Curr Opin Hematol"},{"issue":"21","key":"2411_CR48","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046\u201355.","journal-title":"N Engl J Med"},{"key":"2411_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840767","volume":"13","author":"B Palterer","year":"2022","unstructured":"Palterer B, Salvati L, Capone M, Mecheri V, Maggi L, Mazzoni A, et al. Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature. Front Immunol. 2022;13:840767.","journal-title":"Front Immunol"},{"key":"2411_CR50","unstructured":"Dunn CP, de la Morena MT. CD40 Ligand Deficiency. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle. Copyright \u00a9 1993\u20132025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"issue":"5","key":"2411_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11912-004-0064-8","volume":"6","author":"R Siddiqui","year":"2004","unstructured":"Siddiqui R, Onel K, Facio F, Offit K. The genetics of familial lymphomas. Curr Oncol Rep. 2004;6(5):380\u20137.","journal-title":"Curr Oncol Rep"},{"issue":"38","key":"2411_CR52","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1038\/sj.onc.1207951","volume":"23","author":"RS Houlston","year":"2004","unstructured":"Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene. 2004;23(38):6471\u20136.","journal-title":"Oncogene"},{"issue":"17","key":"2411_CR53","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1182\/blood-2012-06-437210","volume":"121","author":"S Saarinen","year":"2013","unstructured":"Saarinen S, Kaasinen E, Karjalainen-Lindsberg ML, Vesanen K, Aavikko M, Katainen R, et al. Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene. Blood. 2013;121(17):3428\u201330.","journal-title":"Blood"},{"issue":"11","key":"2411_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41408-018-0149-5","volume":"8","author":"JY Chan","year":"2018","unstructured":"Chan JY, Ng AYJ, Cheng CL, Nairismagi ML, Venkatesh B, Cheah DMZ, et al. Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK\/T cell lymphoma. Blood Cancer J. 2018;8(11):111.","journal-title":"Blood Cancer J"},{"issue":"4","key":"2411_CR55","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3324\/haematol.2018.201590","volume":"104","author":"R Burkhard","year":"2019","unstructured":"Burkhard R, Keller I, Arambasic M, Juskevicius D, Tzankov A, Lundberg P, et al. TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-\u03baB mediated signaling in B-cells. Haematologica. 2019;104(4):766\u201377.","journal-title":"Haematologica"},{"issue":"7","key":"2411_CR56","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3324\/haematol.2015.135475","volume":"101","author":"M Rotunno","year":"2016","unstructured":"Rotunno M, McMaster ML, Boland J, Bass S, Zhang X, Burdett L, et al. Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene. Haematologica. 2016;101(7):853\u201360.","journal-title":"Haematologica"},{"issue":"29","key":"2411_CR57","doi-asserted-by":"publisher","first-page":"20377","DOI":"10.18632\/oncotarget.24872","volume":"9","author":"A Lawrie","year":"2018","unstructured":"Lawrie A, Han S, Sud A, Hosking F, Cezard T, Turner D, et al. Combined linkage and association analysis of classical Hodgkin lymphoma. Oncotarget. 2018;9(29):20377\u201385.","journal-title":"Oncotarget"},{"issue":"3","key":"2411_CR58","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bjh.15203","volume":"181","author":"ML McMaster","year":"2018","unstructured":"McMaster ML, Sun C, Landi MT, Savage SA, Rotunno M, Yang XR, et al. Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma. Br J Haematol. 2018;181(3):372\u20137.","journal-title":"Br J Haematol"},{"issue":"3","key":"2411_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1182\/blood-2011-03-341560","volume":"118","author":"S Saarinen","year":"2011","unstructured":"Saarinen S, Aavikko M, Aittomaki K, Launonen V, Lehtonen R, Franssila K, et al. Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood. 2011;118(3):493\u20138.","journal-title":"Blood"},{"issue":"8","key":"2411_CR60","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/ijc.31576","volume":"143","author":"OR Bandapalli","year":"2018","unstructured":"Bandapalli OR, Paramasivam N, Giangiobbe S, Kumar A, Benisch W, Engert A, et al. Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma. Int J Cancer. 2018;143(8):2076\u20138.","journal-title":"Int J Cancer"},{"key":"2411_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fbioe.2020.00179","volume":"8","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Giangiobbe S, Kumar A, Paramasivam N, Dymerska D, Behnisch W, et al. Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing. Front Bioeng Biotechnol. 2020;8:179.","journal-title":"Front Bioeng Biotechnol"},{"issue":"35","key":"2411_CR62","doi-asserted-by":"publisher","first-page":"14920","DOI":"10.1073\/pnas.0904231106","volume":"106","author":"SJ Salipante","year":"2009","unstructured":"Salipante SJ, Mealiffe ME, Wechsler J, Krem MM, Liu Y, Namkoong S, et al. Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci U S A. 2009;106(35):14920\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2411_CR63","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bjh.13295","volume":"170","author":"H Ristolainen","year":"2015","unstructured":"Ristolainen H, Kilpivaara O, Kamper P, Taskinen M, Saarinen S, Leppa S, et al. Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing. Br J Haematol. 2015;170(3):428\u201331.","journal-title":"Br J Haematol"},{"issue":"11","key":"2411_CR64","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood.2022016056","volume":"141","author":"JE Flerlage","year":"2023","unstructured":"Flerlage JE, Myers JR, Maciaszek JL, Oak N, Rashkin SR, Hui Y, et al. Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma. Blood. 2023;141(11):1293\u2013307.","journal-title":"Blood"},{"issue":"1","key":"2411_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/jhg.2013.114","volume":"59","author":"B Rabbani","year":"2014","unstructured":"Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet. 2014;59(1):5\u201315.","journal-title":"J Hum Genet"},{"issue":"12","key":"2411_CR66","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s41431-019-0471-9","volume":"27","author":"TY Tan","year":"2019","unstructured":"Tan TY, Lunke S, Chong B, Phelan D, Fanjul-Fernandez M, Marum JE, et al. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. European journal of human genetics\u202f: EJHG. 2019;27(12):1791\u20139.","journal-title":"European journal of human genetics : EJHG"},{"issue":"18","key":"2411_CR67","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2014.14604","volume":"312","author":"H Lee","year":"2014","unstructured":"Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880\u20137.","journal-title":"JAMA"},{"issue":"5","key":"2411_CR68","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/10428194.2026.2624656","volume":"67","author":"S Ralli","year":"2026","unstructured":"Ralli S, Jones SJ, Leach S, Lynch HJ, Brooks-Wilson AR. Identifying genes and pathways in familial lymphoid cancers using whole exome sequencing. Leuk Lymphoma. 2026;67(5):1014\u201328.","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"2411_CR69","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","volume":"131","author":"L Pasqualucci","year":"2018","unstructured":"Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma. Blood. 2018;131(21):2307\u201319.","journal-title":"Blood"},{"issue":"1","key":"2411_CR70","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/imr.12745","volume":"288","author":"L Pasqualucci","year":"2019","unstructured":"Pasqualucci L. Molecular pathogenesis of germinal center-derived B cell lymphomas. Immunol Rev. 2019;288(1):240\u201361.","journal-title":"Immunol Rev"},{"key":"2411_CR71","doi-asserted-by":"crossref","unstructured":"Andorno R. The right not to know: an autonomy based approach. J Med Ethics. 2004;30(5):435\u20139; discussion 9\u201340.","DOI":"10.1136\/jme.2002.001578"},{"issue":"13","key":"2411_CR72","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1084\/jem.20151074","volume":"212","author":"PN Kelly","year":"2015","unstructured":"Kelly PN, Romero DL, Yang Y, Shaffer AL 3rd, Chaudhary D, Robinson S, et al. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. J Exp Med. 2015;212(13):2189\u2013201.","journal-title":"J Exp Med"},{"issue":"3","key":"2411_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101012","volume":"14","author":"DC Janysek","year":"2021","unstructured":"Janysek DC, Kim J, Duijf PHG, Dray E. Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers. Translational oncology. 2021;14(3):101012.","journal-title":"Translational oncology"},{"issue":"7","key":"2411_CR74","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/jamaoncol.2020.1046","volume":"6","author":"F Petrelli","year":"2020","unstructured":"Petrelli F, Ghidini M, Ghidini A, Tomasello G. Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers: A Systematic Review and Meta-analysis. JAMA Oncol. 2020;6(7):1068\u201371.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2411_CR75","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaci.2012.03.025","volume":"129","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles C, Maglione PJ. Common variable immunodeficiency. J Allergy Clin Immunol. 2012;129(5):1425\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2411_CR76","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d\u2019Enghien C, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202\u20138.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2411_CR77","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1182\/blood.2022016975","volume":"141","author":"S Elitzur","year":"2023","unstructured":"Elitzur S, Vora A, Burkhardt B, Inaba H, Attarbaschi A, Baruchel A, et al. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy. Blood. 2023;141(7):743\u201355.","journal-title":"Blood"},{"key":"2411_CR78","doi-asserted-by":"crossref","unstructured":"Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K, et al. Hematologic malignancies and Li-Fraumeni syndrome. Cold Spring Harb Mol Case Stud. 2019;5(1):a003210.","DOI":"10.1101\/mcs.a003210"},{"issue":"8","key":"2411_CR79","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/humu.20501","volume":"28","author":"J German","year":"2007","unstructured":"German J, Sanz MM, Ciocci S, Ye TZ, Ellis NA. Syndrome-causing mutations of the BLM gene in persons in the Bloom\u2019s Syndrome Registry. Hum Mutat. 2007;28(8):743\u201353.","journal-title":"Hum Mutat"},{"issue":"5","key":"2411_CR80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/bjc.1994.431","volume":"70","author":"CA Stiller","year":"1994","unstructured":"Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study. Br J Cancer. 1994;70(5):969\u201372.","journal-title":"Br J Cancer"},{"issue":"3","key":"2411_CR81","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.pathol.2023.01.002","volume":"55","author":"F Fareez","year":"2023","unstructured":"Fareez F, Wang BH, Brain I, Lu JQ. Lymphomas in patients with neurofibromatosis type 1 (NF1): another malignancy in the NF1 syndrome? Pathology. 2023;55(3):302\u201314.","journal-title":"Pathology"},{"issue":"12","key":"2411_CR82","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41431-024-01708-6","volume":"32","author":"C Colas","year":"2024","unstructured":"Colas C, Guerrini-Rousseau L, Suerink M, Gallon R, Kratz CP, Ayuso E, et al. ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management. European journal of human genetics\u202f: EJHG. 2024;32(12):1526\u201341.","journal-title":"European journal of human genetics : EJHG"},{"issue":"3","key":"2411_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejmg.2015.12.014","volume":"59","author":"T Ripperger","year":"2016","unstructured":"Ripperger T, Schlegelberger B. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome. Eur J Med Genet. 2016;59(3):133\u201342.","journal-title":"Eur J Med Genet"},{"key":"2411_CR84","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-0-387-72005-0_6","volume":"601","author":"I Kondratenko","year":"2007","unstructured":"Kondratenko I, Paschenko O, Polyakov A, Bologov A. Nijmegen breakage syndrome. Adv Exp Med Biol. 2007;601:61\u20137.","journal-title":"Adv Exp Med Biol"},{"issue":"22","key":"2411_CR85","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1182\/blood.2023023336","volume":"143","author":"CS Escherich","year":"2024","unstructured":"Escherich CS, Chen W, Li Y, Yang W, Nishii R, Li Z, et al. Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children. Blood. 2024;143(22):2270\u201383.","journal-title":"Blood"},{"key":"2411_CR86","unstructured":"JM F. Neurofibromatosis 1. Adam MP BS, Mirzaa GM, et al., editors. , editor. [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025. University of Washington, Seattle; 1993\u20132025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1109\/1998 Oct 2 [Updated 2025 Apr 3]."},{"issue":"1","key":"2411_CR87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00203-025-04572-0","volume":"208","author":"T Xie","year":"2025","unstructured":"Xie T, Shi C. Recent advances in infections as risk factors for lymphoma: a review of the effects of viral, bacterial, and fungal infections in lymphoma. Arch Microbiol. 2025;208(1):5.","journal-title":"Arch Microbiol"},{"key":"2411_CR88","unstructured":"Chandra S, Nagaraj CB, Sun M, Chandrakasan S, Zhang K. WAS-Related Disorders. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle. Copyright \u00a9 1993\u20132025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"key":"2411_CR89","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"2411_CR90","doi-asserted-by":"crossref","unstructured":"Hirabayashi M, Georges D, Combes JD, Clifford GM. Attributable Fraction of Epstein-Barr Virus in Subtypes of Lymphoma: A Systematic Review and Global Meta-Analysis. Int J Cancer. 2026.","DOI":"10.1002\/ijc.70468"},{"issue":"35","key":"2411_CR91","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1200\/JCO.22.00668","volume":"40","author":"M Merli","year":"2022","unstructured":"Merli M, Rattotti S, Spina M, Re F, Motta M, Piazza F, et al. Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi. J Clin Oncol. 2022;40(35):4060\u201370.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2411_CR92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.seminhematol.2022.11.003","volume":"59","author":"C Mazzaro","year":"2022","unstructured":"Mazzaro C, Bomben R, Gragnani L, Visentini M, Pozzato G, Pozzo F, et al. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy. Semin Hematol. 2022;59(4):177\u201382.","journal-title":"Semin Hematol"},{"key":"2411_CR93","doi-asserted-by":"publisher","first-page":"1794939","DOI":"10.3389\/fonc.2026.1794939","volume":"16","author":"Y Samaha","year":"2026","unstructured":"Samaha Y, Hugo H, Asrani R. Adult T-cell leukemia\/lymphoma: molecular pathogenesis, emerging therapies, and future directions. Front Oncol. 2026;16:1794939.","journal-title":"Front Oncol"},{"issue":"8","key":"2411_CR94","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JOP.2017.021907","volume":"13","author":"N Mehta-Shah","year":"2017","unstructured":"Mehta-Shah N, Ratner L, Horwitz SM. Adult T-Cell Leukemia\/Lymphoma. J Oncol Pract. 2017;13(8):487\u201392.","journal-title":"J Oncol Pract"},{"issue":"16","key":"2411_CR95","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1182\/blood-2019-01-893339","volume":"133","author":"K Lurain","year":"2019","unstructured":"Lurain K, Polizzotto MN, Aleman K, Bhutani M, Wyvill KM, Goncalves PH, et al. Viral, immunologic, and clinical features of primary effusion lymphoma. Blood. 2019;133(16):1753\u201361.","journal-title":"Blood"},{"key":"2411_CR96","doi-asserted-by":"crossref","unstructured":"Gathers DA, Galloway E, Kelemen K, Rosenthal A, Gibson SE, Munoz J. Primary effusion lymphoma: a clinicopathologic perspective. Cancers. 2022;14(3):722.","DOI":"10.3390\/cancers14030722"},{"issue":"1","key":"2411_CR97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jvh.13183","volume":"27","author":"A Marrone","year":"2020","unstructured":"Marrone A, Ciotti M, Rinaldi L, Adinolfi LE, Ghany M. Hepatitis B and C virus infection and risk of haematological malignancies. J Viral Hepat. 2020;27(1):4\u201312.","journal-title":"J Viral Hepat"},{"issue":"10","key":"2411_CR98","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.annonc.2024.06.003","volume":"35","author":"K Hubel","year":"2024","unstructured":"Hubel K, Bower M, Aurer I, Bastos-Oreiro M, Besson C, Brunnberg U, et al. Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(10):840\u201359.","journal-title":"Ann Oncol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02411-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02411-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02411-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:11:19Z","timestamp":1788531079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02411-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2411"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02411-9","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"141"}}